Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 451-475 of 671 matching filings.

Per page
25
Current page
19
8-K File 001-33357

FORM 8-K

Filing date
19 Oct 2015
Reporting date
19 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Oct 2015
Reporting date
12 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A

Filing date
01 Oct 2015
Reporting date
08 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
09 Sep 2015
Reporting date
09 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
10 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G

Filing date
09 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 May 2015
Reporting date
23 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 May 2015
Reporting date
23 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 May 2015
Reporting date
23 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
07 May 2015
Reporting date
23 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-203960

S-8

Filing date
07 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
07 May 2015
Reporting date
07 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC-13G

Filing date
21 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

SC 13G filing

Filing date
20 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 Mar 2015
Reporting date
12 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50118

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 Feb 2015
Reporting date
12 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A filing

Filing date
11 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
02 Feb 2015
Reporting date
02 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-50118

SC 13G/A filing

Filing date
29 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
08 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .